Eplly is Your Ultimate Source for the Latest News, Science, Health, Fashion, Education, Family, Music and Movies.
—— 《 Eplly • Com 》
HIBEGONE: The First Product That Can Get Rid of the Effects of THC in 15 Minutes
Views: 4783
2023-08-22 21:18
LOS ANGELES--(BUSINESS WIRE)--Aug 22, 2023--

LOS ANGELES--(BUSINESS WIRE)--Aug 22, 2023--

Ever miscalculated your cannabis intake, drifting into uncharted territories of daze and confusion? Before the onset of munchies or anxiety strikes, there's a new hero in the arena. Introducing HIBEGONE, the innovative formula promising to steer you back to a balanced state.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230822771685/en/

(Graphic: HiBeGone.com)

In a landmark development, HIBEGONE has unveiled its fast-acting shot designed to rapidly balance out the effects of cannabis, delivering heightened clarity and awareness within minutes. Harnessing the power of natural ingredients, HIBEGONE promises to be the answer for those seeking to rapidly reduce the negative effects of THC and essentially reverse their high.

Born from the pursuits of four Los Angeles-based entrepreneurs initially attempting to create a cognitive enhancement drink that could suppress appetite, HIBEGONE serendipitously emerged as a beacon of clarity in the cannabis world. The proprietary blend of L-theanine, alpha GPC, and THCV ensures users regain their mental sharpness and break free from the "high" often linked with THC, with effects being noticeable in as little as 15 minutes.

But what sets HIBEGONE apart? The science behind its potency. With THCV acting as a CB1 inverse agonist, it naturally counteracts THC's effects, negating its potency. By consuming HIBEGONE, the patent-pending formula binds to the receptor, severing the connection between the receptor and THC. This combined with HIBEGONE's fast-acting technology, which initiates absorption right from the mouth and esophagus, users can experience rapid relief from the myriad of unpleasant cannabis effects we all experience from time to time.

Furthermore, the addition of renowned nootropics L-theanine and alpha GPC enhances the cognitive benefits, positioning HIBEGONE as more than just a remedy – but also a cognitive enhancer. The product's practicality is also undeniable, with a simple shake-and-drink mechanism making it easy for users to optimize their high, whether taken before or after cannabis consumption.

Exciting times are ahead for the cannabis community with the official launch of HIBEGONE! Crafted meticulously with ingredients tailored to counteract those overwhelming cannabis moments, this revolutionary formula is all set to make its mark. While you can soon find it in dispensaries, eager customers can get a head start by purchasing directly from their website.

Made in the USA, HIBEGONE is not just another wellness product; it’s a beacon of reassurance for the cannabis community. With HIBEGONE, you're not just purchasing a product; you're investing in peace of mind for those moments when you might've ventured a bit too far into the cannabis cosmos.

This product has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Keep out of reach of children. HIBEGONE is not guaranteed to work with everyone or alleviate every side effect of THC. If side effects persist you may need to seek medical attention. Always consult a physician before taking a dietary supplement. HIBEGONE is not intended for those who are pregnant and/or nursing. People with a medical condition and those taking medication should consult a physician before use. We do not recommend exceeding one HIBEGONE per day.

View source version on businesswire.com:https://www.businesswire.com/news/home/20230822771685/en/

CONTACT: Troy Anderlohr

info@hibegone.com

KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: OTHER CONSUMER HEALTH GENERAL HEALTH CANNABIS WOMEN FOOD/BEVERAGE VITAMINS/SUPPLEMENTS MEN NATURAL RESOURCES RETAIL CONSUMER

SOURCE: HIBEGONE

Copyright Business Wire 2023.

PUB: 08/22/2023 09:01 AM/DISC: 08/22/2023 09:01 AM

http://www.businesswire.com/news/home/20230822771685/en